APC resistance and oral contraceptives;APC-RESISTENZ UND ORALE ANTIKONZEPTIVA

Geburtshilfe und Frauenheilkunde

Volumn 56, Issue 5, 1996, Pages 231-233

  Kreis, I ^a,c   Weiss, Th ^a   Rabe, Th N ^b   Ziegler, R ^a   Nawroth, P P ^a  

^a Abt I   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ORAL CONTRACEPTIVE AGENT;

ANTICOAGULATION; ARTICLE; DRUG SAFETY; FEMALE; HIGH RISK POPULATION; HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; RISK ASSESSMENT; THROMBOSIS;

EID: 0029937015     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1022265     Document Type: Article

References (21)

1. Dahlbäck, B.: New molecular insights into the genetics of thrombophilia. Thromb. Haemost. 74 (1995) 139-148
2. Dahlbäck, B.: Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 85 (1995) 607-614
3. Esmon, C. T.: Molecular events that control the protein C anticoagulant pathway. Thromb. Haemost. 70 (1993) 29-35
4. Esmon, C. T.: The protein C anticoagulant pathway. Arterioscler. Thromb. 12 (1995) 135-140
5. Esmon, C. T.: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264 (1989) 4743-4746
6. Walker, F. J., P. J. Fay: Regulation of blood coagulation by the protein C system. FASEB J. 6 (1992) 2561-2567
7. Nawroth, P. P., R. Ziegler: Die Pille als vaskulärer Risikofaktor: Sind molekulare Mechanismen bekannt? Klin. Wochenschr. 69 (1991) 335-339
8. Malm, J., M. Laurell, I. M. Nilsson, B. Dahlbäck: Thromboembolic disease - Critical evaluation of laboratory investigation. Thromb. Haemost. 68 (1992) 7-13
9. Heijboer, H., D. Brandjes, H. R. Büller, A. Sturk, J. W. Ten Cate: Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N. Engl. J. Med. 323 (1990) 1512-1516
10. Taberno, M. D., J. F. Tomas, I. Alberca, A. Orfao, A. L Borrasca, V. Vicente: incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am. J. Hematol. 36 (1991) 249-254
11. Svensson, P. J., B. Dahlbäck: Resistance to activated protein C as a basis for venous thrombosis. N. Engl. J. Med. 330 (1994) 517-522
12. Bertina, R. M., B. Koeleman, T. Koster, F. R. Rosendaal, R. J. Dirven, H. de Ronde, P. A. van der Velden, P. H. Reitsma: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369 (1994) 64-67
13. Rosendaal, F. R., T. Koster, J. P. Vandenbroucke, P. H. Reitsma: High risk of thrombosis in patients homozygous for factor V Leiden. Blood 85 (1995) 1504-1508
14. Bobby, P. C., P. Koeleman, H. Reitsma, C F. Allaart, R. M. Bertina: Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 84 (1994) 1031-1035
15. Shen, L., B. Dahlbäck: Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J. Biol. Chem. 269 (1994) 18735-18738
16. Odegaard, B., G. M. Kenneth: Proteolysis of factor Va and factor Xa by activated protein C. J. Biol. Chem. 262 (1987) 11233-11238
17. Kalafatis, M., G. M. Kenneth: Role of the membrane in the inactivation of factor Va by activated protein C. J. Biol. Chem. 268 (1993) 27246-27257
18. Ridker, P. M., C H. Hennekens, K. Lindpaintner, M. J. Stampfer, P. R. Eisenberg, J. P. Miletich: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men. N. Engl. J. Med. 332 (1995) 912-917
19. Sun, X., B. Evatt, J. H. Griffin: Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 83 (1994) 3120-3125
20. Zöller, B., P. J. Svensson, X. He, B. Dahlbäck: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J. Clin. Invest 94 (1994) 2521-2524
21. Vandenbroucke, J. P., T. Koster, E. Briet, P. H. Reitsma, R. M. Bertina, F. R. Rosendaal: Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344 (1994) 1453-1457